Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Georgia for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Georgia only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Georgia (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Nicholas Mayfield (NPI 1467479089)

Field	Value
Entity Type	Individual
Organization	Nicholas Mayfield
Address	2616 Warm Springs Rd
City	Columbus
State	GA
ZIP	31904
Taxonomy	Ophthalmology Physician
NPI Enumerated	July 17, 2006

Payer Source	Total Paid
Medicare	$2.6M
Medicaid	$0

Key Findings

This profile is effectively single‑payer in practice: total Medicare revenue is $2.6M and there is no Medicaid billing on file, so the provider’s revenue base is concentrated in Medicare reimbursement rather than a mixed Medicaid/Medicare payer mix. That concentration means analyses of utilization and reimbursement should treat Medicare as the sole material public payer for this NPI.

Revenue is highly concentrated in a very small set of codes: the precomputed top 3 Medicare codes account for 84.8% of this provider’s total Medicare revenue. Those top drivers are J2777 ($1.1M, 43.2%), J0178 ($922.1K, 35.6%), and 67028 ($153.8K, 5.9%), indicating that a few therapies dominate income.

The code mix indicates a retina‑focused, injection‑driven ophthalmology practice: the highest‑revenue codes are intravitreal injection drugs (J2777, J0178) and vitreous injection procedures (67028), supplemented by diagnostic retinal imaging (92134). The billing pattern — including J2777 at 38.6K claims with $29 avg paid/claim and J0178 at 1.4K claims with $681 avg paid/claim — shows a mix of very high volume/lower unit payment items and lower volume/high unit payment biologic drug billing.

Competitive standing varies by service line. For J2777 the provider ranks #176 of 2039 providers nationally (91th percentile; typical, unremarkable volume for this code), and for J0178 the provider ranks #934 of 3204 (71th percentile; typical, unremarkable volume for this code), signaling solid national positioning on intravitreal drug administration; by contrast the provider is an extreme outlier on retinal imaging, with 92134 ranking #732 of 26868 providers nationally (97th percentile; extreme outlier, far above typical national volume for this code), which suggests unusually high imaging and monitoring activity compared with peers.

Office/outpatient E/M and routine ophthalmology codes contribute only modestly to revenue but appear above typical volumes for some categories: 99213 generated $37.7K from 629 claims (1.5% of Medicare revenue) and ranks #17744 of 457151 providers nationally (96th percentile; notably above typical national volume for this code), while 92014 produced $36.8K from 466 claims (1.4% of Medicare revenue) and sits at the 83th percentile. This pattern reinforces that the practice’s primary revenue drivers are procedure and drug reimbursement rather than E/M visits, even though E/M volume is elevated.

Surgical retina activity is present but limited: 67041 generated $11.2K from 13 claims and 67036 generated $10.8K from 16 claims (each ~0.4% of Medicare revenue), with national ranks that place these volumes well below high‑volume surgical retina centers. These low absolute counts and revenue shares indicate occasional surgical interventions rather than a surgery‑heavy practice model.

The provider has long tenure under the current NPI (enumerated 2006-07-17, approximately 20 years ago), indicating an established Medicare billing history that can support longitudinal trend analysis and suggests sustained referral relationships for retinal care. Given the long enumeration and the concentration in injection/monitoring services, the practice appears to be a stable outpatient retina/injectable therapy provider.

From an operational and reimbursement risk perspective, this profile is sensitive to changes in intravitreal drug utilization or reimbursement because a large share of Medicare revenue is tied to a small set of drug/procedure codes. With no Medicaid revenue to diversify payer exposure and 84.8% of Medicare revenue coming from the top three codes, shifts in coverage policy, drug pricing, or coding guidelines for these specific codes could materially affect overall revenue.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

16 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J2777	Injection, faricimab‑svoa, 0.1 mg	38,580	$30	$1.1M
J0178	Injection, aflibercept, 1 mg	1,350	$680	$922.1K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,730	$90	$153.8K
J2778	Injection, ranibizumab, 0.1 mg	790	$170	$133.8K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	2,380	$30	$64.3K
J7312	Injection, dexamethasone, intravitreal implant, 0.1 mg	310	$160	$47.7K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	630	$60	$37.7K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	470	$80	$36.8K
J9035	Injection, bevacizumab, 10 mg	600	$60	$33.1K
67041	In this procedure, the provider removes scar tissue from the retinal membrane that obscures vision. He removes vitreous humor, the gelatinous material that gives shape to the eye, using a mechanical…	10	$860	$11.2K

Showing 1–10 of 16

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 16 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Georgia Distribution

Nicholas Mayfield — 3 of 16 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Georgia

Full comparison — all codes billed, vs. state median

16 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	21	70	970	$680	$700.6K
J2777	5	40	14,100	$30	$524.3K
J2778	18	30	1,170	$180	$286.2K
67028	10	80	720	$90	$71.9K
J7312	3	10	220	$160	$37.6K
67041	4	10	10	$1,140	$30.7K
67036	5	10	20	$1,120	$23.6K
92014	149	850	130	$80	$19.7K
99214	7,467	13,640	120	$80	$17.8K
J9035	3	70	120	$50	$10.3K

Showing 1–10 of 16

Related Providers

Other providers that share a Tax Identification Number (TIN) with Nicholas Mayfield, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Finny John	KS	Ophthalmology Physician	$395.3K	$0
West Georgia Eye Care Center, PA	GA	Ophthalmology Physician	$0	$326K
Bret Crumpton	GA	Ophthalmology Physician	$306.5K	$0
Sterling Cannon	GA	Ophthalmology Physician	$292.5K	$0
Malcolm Moore	GA	Ophthalmology Physician	$276.7K	$0
John Ervin	GA	Ophthalmology Physician	$167.4K	$0

Nearby Providers

Other providers in the same ZIP code as Nicholas Mayfield, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Panvelkar And Panvelkar, LLC	GA	Pediatrics Physician	$0	$2.3M
The Allergy Center At Brookstone PC	GA	Allergy & Immunology Physician	$0	$1.9M
Eye Surgery Center Of West Georgia LLC	GA	Ambulatory Surgical Clinic/Center	$1.4M	$0
Candler Road Dental, PC	GA	General Practice Dentistry	$0	$932.8K
Hiren Shah	GA	Cardiovascular Disease Physician	$757.1K	$0
Hunter Champion	GA	Cardiovascular Disease Physician	$744.8K	$0
Shane Darrah	GA	Interventional Cardiology Physician	$700K	$0
Gregory Parker	GA	Family Medicine Physician	$699.8K	$0
I Basilio Md, PC	GA	Pediatric Adolescent Medicine Physician	$0	$697K
William Harper	GA	Specialist	$678.4K	$0

Nicholas Mayfield — Billing Profile & Reimbursement Data

Sign up for Nicholas Mayfield — Billing Profile & Reimbursement Data policy alerts

Nicholas Mayfield — Billing Profile & Reimbursement Data

Sign up for Nicholas Mayfield — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References